Ocular implant project receives €1.4 million

Article

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

The grant has been issued to alamedics, Offenhäuser & Berger, the Max-Planck Institute for Intelligent Systems and the Laser Institute in order to develop a new generation of ocular implants for glaucoma.

Dr Christian Lingenfelder, general manager of alamedics and coordinator of the project group, explained, "The implants will allow for better control of intraocular pressure. The newly designed surfaces of artificial intraocular lenses, a combination of innovative materials and nanostructures, will allow for significantly better night vision. Additionally, the interaction of implant and body after implantation will be much better controlled."

Dr Schavan commented, "The BIOSURF research group over the next three years wants to explore new biomaterials and to create nanostructures, which allow controlled interaction of the human body with the implants. To better control the function and durability of the implant, the biomimetic structures researched in this project, will support regeneration of the interface between implant and body."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.